Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says
By Katherine Dillinger, CNN (CNN) — A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound…
Continue Reading